Ocular Therapeutix, Inc.OCULNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+17.9%
5Y CAGR+19.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+17.9%/yr
vs +32.0%/yr prior
5Y CAGR
+19.0%/yr
Consistent
Acceleration
-14.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$118.30M+15.7%
2024$102.24M+37.3%
2023$74.49M+3.2%
2022$72.15M+7.6%
2021$67.07M+35.6%
2020$49.47M+6.1%
2019$46.61M+96.4%
2018$23.73M-27.0%
2017$32.51M+83.6%
2016$17.70M-